P

Assignee

PHARMACYCLICS INC

US67 patents

Top patents by PatentIndex Score

US9212185B2Dec 15, 2015

Inhibitors of Bruton's tyrosine kinase

PHARMACYCLICS INC44 citations99
US9206189B2Dec 8, 2015

Inhibitors of bruton's tyrosine kinase

PHARMACYCLICS INC41 citations99
US9193735B2Nov 24, 2015

Inhibitors of Bruton's tyrosine kinase

PHARMACYCLICS INC41 citations99
US9181257B2Nov 10, 2015

Inhibitors of Bruton's tyrosine kinase

PHARMACYCLICS INC65 citations99
US9133202B2Sep 15, 2015

Inhibitors of Bruton's tyrosine kinase

PHARMACYCLICS INC37 citations99
US9133198B2Sep 15, 2015

Inhibitors of bruton'S tyrosine kinase

PHARMACYCLICS INC36 citations99
US9133201B2Sep 15, 2015

Inhibitors of Bruton's tyrosine kinase

PHARMACYCLICS INC35 citations99
US9127012B2Sep 8, 2015

Inhibitors of bruton's tyrosine kinase

PHARMACYCLICS INC37 citations99
US8975266B2Mar 10, 2015

Inhibitors of Bruton's tyrosine kinase

PHARMACYCLICS INC42 citations99
US8957079B2Feb 17, 2015

Inhibitors of Bruton's tyrosine kinase

PHARMACYCLICS INC78 citations99
US8759516B2Jun 24, 2014

Inhibitors of Bruton's tyrosine kinase

PHARMACYCLICS INC44 citations99
US8377946B1Feb 19, 2013

Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors

PHARMACYCLICS INC114 citations99
US8008309B2Aug 30, 2011

Inhibitors of bruton's tyrosine kinase

PHARMACYCLICS INC155 citations99
US7960396B2Jun 14, 2011

Inhibitors of Bruton's tyrosine kinase

PHARMACYCLICS INC142 citations99
US7825118B2Nov 2, 2010

Inhibitors of bruton's tyrosine kinase

PHARMACYCLICS INC146 citations99
US7741330B1Jun 22, 2010

Pyrazolo-pyrimidine inhibitors of Bruton's tyrosine kinase

PHARMACYCLICS INC163 citations99
US7732454B2Jun 8, 2010

Inhibitors of Bruton's tyrosine kinase

PHARMACYCLICS INC138 citations99
US7718662B1May 18, 2010

Pyrazolo-pyrimidine inhibitors of bruton's tyrosine kinase

PHARMACYCLICS INC213 citations99
US7514444B2Apr 7, 2009

Inhibitors of bruton's tyrosine kinase

PHARMACYCLICS INC423 citations99
US5599928AFeb 4, 1997

Texaphyrin compounds having improved functionalization

PHARMACYCLICS INC894 citations99
US9181263B2Nov 10, 2015

Inhibitors of bruton's tyrosine kinase

PHARMACYCLICS INC40 citations98
US9125889B2Sep 8, 2015

Use of inhibitors of Bruton's tyrosine kinase (Btk)

PHARMACYCLICS INC63 citations98
US9107924B2Aug 18, 2015

Inhibitors of Bruton'S tyrosine kinase for the treatment of solid tumors

PHARMACYCLICS INC40 citations98
US8999999B2Apr 7, 2015

Use of inhibitors of Bruton's tyrosine kinase (Btk)

PHARMACYCLICS INC66 citations98
US5817017AOct 6, 1998

Medical devices and materials having enhanced magnetic images visibility

PHARMACYCLICS INC157 citations98
US5776925AJul 7, 1998

Methods for cancer chemosensitization

PHARMACYCLICS INC96 citations97
US6270749B1Aug 7, 2001

Use of Texaphyrin in ocular diagnosis and therapy

PHARMACYCLICS INC119 citations96
US5756726AMay 26, 1998

Methods of producing singlet oxygen using compounds having improved functionalization

PHARMACYCLICS INC65 citations96
US5601802AFeb 11, 1997

Methods of MRI enhancement using compounds having improved functionalization

PHARMACYCLICS INC39 citations96
US5591422AJan 7, 1997

Texaphyrin complexes having improved functionalization

PHARMACYCLICS INC63 citations96
US5594136AJan 14, 1997

Texaphyrin solid supports and devices

PHARMACYCLICS INC84 citations95
US7276612B2Oct 2, 2007

Hydroxamates as therapeutic agents

PHARMACYCLICS INC39 citations94
US8779171B2Jul 15, 2014

Hydroxamates as therapeutic agents

PHARMACYCLICS INC9 citations92
US8026371B2Sep 27, 2011

Hydroxamates as therapeutic agents

PHARMACYCLICS INC9 citations92
US7834054B2Nov 16, 2010

Hydroxamates as therapeutic agents

PHARMACYCLICS INC16 citations92
US7517988B2Apr 14, 2009

Hydroxamates as therapeutic agents

PHARMACYCLICS INC13 citations92
US7482466B2Jan 27, 2009

Hydroxamates as therapeutic agents

PHARMACYCLICS INC13 citations92
US7479502B2Jan 20, 2009

2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors

PHARMACYCLICS INC15 citations92
US7420089B2Sep 2, 2008

Hydroxamates as therapeutic agents

PHARMACYCLICS INC17 citations92
US6096030AAug 1, 2000

Light delivery catheter and PDT treatment method

PHARMACYCLICS INC45 citations92
US5888997AMar 30, 1999

Radiation sensitization using texaphyrins

PHARMACYCLICS INC24 citations92
US6022526AFeb 8, 2000

Use of texaphyrins in detection of melanin and melanin metabolites diagnostic of melanotic melanoma

PHARMACYCLICS INC25 citations90
US5886173AMar 23, 1999

Metallation of macrocycles with 2,4-dicarbonyl-metal complexes

PHARMACYCLICS INC50 citations89
US5775339AJul 7, 1998

Photodynamic therapy of pigment-related lesions

PHARMACYCLICS INC34 citations89
US7625880B2Dec 1, 2009

Inhibitors of tyrosine kinases and uses thereof

PHARMACYCLICS INC9 citations84
US6825186B1Nov 30, 2004

Method and compositions for treating atheroma, tumors and other neoplastic tissue

PHARMACYCLICS INC15 citations84
US7547689B2Jun 16, 2009

Methods and compositions for treating atheroma, tumors and other neoplastic tissues

PHARMACYCLICS INC12 citations83
US8900565B2Dec 2, 2014

Indole derivatives as inhibitors of histone deacetylase

PHARMACYCLICS INC5 citations82
US7160873B2Jan 9, 2007

Texaphyrin coordination compounds and uses thereof

PHARMACYCLICS INC11 citations78
US7820711B2Oct 26, 2010

Uses of selective inhibitors of HDAC8 for treatment of T-cell proliferative disorders

PHARMACYCLICS INC7 citations74

Showing the top 50 of 67 patents by PatentIndex Score.